The year in cardiovascular medicine 2021: interventional cardiology

█ Current opinion

Authors:
Javier Escaned¹, Farouc A. Jaffer², Julinda Mehilli³, Roxana Mehran^4
1Hospital Clínico San Carlos IDISCC, Complutense University of Madrid, Madrid, Spain
²Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
³Medizinische Klinik I, Landshut-Achdorf Hospital, Landshut, Klinikum der Universitaet München,
Ludwig-Maximilians-Universitaet and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
⁴The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Corresponding author. Tel: +34 91 3303438, Fax: +34 91 3303289, Email: escaned@secardiologia.es

Preamble
Since last year’s report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around the globe. In our yearly review, we shall revisit the developments in percutaneous coronary intervention (PCI), structural heart interven­tions, and adjunctive pharmacotherapy.

ISSUE: CARDIOLOGIA HUNGARICA | 2023 | VOLUME 53, ISSUE 1

click here to read the full article

click here to read the pdf

---